The Insomnia Market covers a wide range of therapeutic solutions designed to address different sleep related conditions. Market Research Future segments the market by type of therapy, drug formulation, type of disease condition, and geography. The market is projected to grow at a CAGR of 5.8% between 2025 and 2035.

Pharmacological therapy currently dominates the market and accounted for approximately 68% of the market in 2024. Prescription medications continue to be widely used because they can provide relatively rapid relief for certain insomnia symptoms. However, concerns related to long-term medication use, side effects, and dependency are encouraging interest in non-pharmacological approaches.

Non-pharmacological therapy is emerging as a rapidly developing segment. CBT-I, mindfulness practices, behavioral interventions, lifestyle modifications, and digital therapeutics can address behavioral and psychological factors associated with sleep difficulties.

By drug formulation, capsules represent the leading category, while tablets also account for a substantial share. Formulation development continues to focus on convenience, dosage flexibility, and patient preferences.

Poor quality of sleep represents the largest disease-condition segment, while sleep-maintenance problems are gaining increasing attention. These conditions can be influenced by stress, lifestyle factors, aging, and other health concerns.

Future market development is expected to emphasize personalized therapies, digital sleep solutions, remote monitoring, and evidence-based behavioral interventions. These trends can expand treatment choices while supporting more individualized approaches to insomnia management.